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Liver transplantation has become established as the treat-
ment of choice for most patients with end-stage liver disease
and is performed on a routine basis in most major centres
throughout the world. The majority of donors for liver trans-
plantation are brain-dead cadaver donors following either a
severe head injury or a massive intracranial haemorrhage.
Potential liver donors undergo a rigid screening process
before being accepted. This includes a thorough clinical
examination to assess the haemodynamic status of the donor
and to exclude any overt evidence of liver disease. Blood
samples are also taken for viral studies to exclude HIV infec-
tion and hepatitis B and C infection, and for liver function
tests to exclude liver disease or liver injury.
Over the years we have noted that our liver donors often
had low serum albumin levels, although this has not been
formally documented. A review of the literature revealed that
hypoalbuminaemia associated with severe head injury has
been documented previously. However the impact of brain
death on serum albumin levels has not been studied previ-
ously. The present study was therefore undertaken to docu-
ment serum albumin levels in brain-dead cadaver donors.
Patients and methods
We retrospectively reviewed the charts of the 37 brain-dead
patients referred to the organ transplant unit at Groote
Schuur Hospital in 2001 and 2002 as potential donors for
liver transplantation.
All potential donors were assessed, investigated and man-
aged according to standard protocols. The assessment con-
sisted of taking an in-depth history from the family and doing
a thorough physical examination of the donor to exclude any
serious illnesses in the past, use of any medication that could
compromise the liver, and any psychosocial behaviour that
could potentially place the recipient at an increased risk of
acquiring certain transmissible diseases. Periods of haemody-
namic instability in relation to the injury were also noted.
The investigations included blood tests for blood group, full
blood count, viral studies for HIV, hepatitis B and C and
cytomegalovirus (CMV), and renal and liver function tests.
The latter included serum aspartate transaminase (AST),
alanine aminotransferase (ALT), alkaline phosphatase, gam-
maglutaryl transferase (GGT), total protein, albumin and
bilirubin levels.
The donors were carefully monitored to ensure adequate
ventilation and haemodynamic stability. Intravenous fluids
were administered according to urine output and haemody-
namic status. Occasionally inotropic support was required
for haemodynamic instability.
The charts of the patients were reviewed and demographic
data, cause of brain death, time of the injury, time of certifi-
cation of brain death, use of inotropic support, and biochem-
ical and haemotological data were recorded. The results were
analysed statistically using STATA corp 2001 statistical soft-
ware
Results
The 37 potential donors for liver transplantation referred to
the organ transplant unit at Groote Schuur Hospital between
January 2001 and December 2002 were included in the
study. There were 22 males and 15 females with an average
age of 27.8 ± 10.7 years (range 3 - 52 years). The mean
height of the patients was 1.73 ± 0.1 m (range 0.9 - 2.0 m)
and the mean weight was 69.6 ± 19.5 kg (range 15 - 120 kg).
Fifteen patients were blood group A, 15 were blood group O,
5 were blood group B and 2 were blood group AB.
The causes of brain death are shown in Fig. 1. In the
majority of cases brain death was trauma related. The cause
of brain death was a motor vehicle accident in 30% of cases,
assault in 16%, a gunshot wound to the head in 16% and a
fall in 8%. In only 30% of the patients was the brain death
related to a cerebrovascular accident (CVA). 
The time between the injury/CVA and referral to the organ
transplant unit is shown in Fig. 2. The majority of patients
were referred more than 20 hours after the injury/CVA. Only
9 patients were referred within 10 hours, and 9 patients were
referred more than 30 hours after the injury/CVA.
The time since certification of brain death and referral to
the organ transplant unit is shown in Fig. 3. In 22 patients
the blood tests had been undertaken within 10 hours of certi-
fication of brain death. In 7 patients the blood tests had been
undertaken more than 20 hours after certification of brain
death.
The serum electrolyte levels are shown in Table I. Serum
sodium, potassium, urea, creatinine, calcium, and glucose
levels were all within the normal range.
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The results of liver function tests are shown in Table II.
The serum alkaline phosphatase, GGT, ALT, AST, lactate
dehydrogenase and total bilirubin were all within the normal
range. However the mean total protein was 49.4 ± 41 and
the mean serum albumin 23.3 ± 7.4, both of which were sig-
nificantly below the normal range. The distribution of the
protein levels is shown in Fig. 4. Only 2 patients had total
protein levels within the normal range. The distribution of
the serum albumin levels is shown in Fig. 5. Only 1 patient
had a serum albumin level in the normal range.
Seventy per cent of the patients had received inotropic
support to maintain haemodynamic stability. The mean
serum albumin level in the patients who received inotropic
support was 22 g/l compared with 25 g/l in the patients who
did not receive inotropic support (p > 0.05) (Fig. 6).
The effect of the cause of brain death on serum albumin
levels is shown in Fig. 7. Serum albumin levels were signifi-
cantly lower in the patients who had trauma (21 g/l) com-
pared with the CVA patients (28 g/l) (p < 0.05).
There was no effect of the time since injury/CVA on serum
albumin levels. The patients referred to the transplant unit
within 20 hours of the injury/CVA had a serum albumin
level of 23 g/l, compared with a serum albumin level of 25 g/l
in the patients referred more than 20 hours after the
injury/CVA (p > 0.05). Similarly, the patients referred within
10 hours of certification of brain death had a serum albumin
level of 23 g/l, compared with a serum albumin level of 25 g/l
in the patients referred more than 10 hours after certification
of brain death (p > 0.05).
Discussion
In this study we have documented significant hypoalbu-
minaemia and hypoproteinaemia in brain-dead patients who
had been referred to the organ transplant unit as potential
donors for liver transplantation. The liver function tests are
used as part of the screening process for the acceptability of
potential brain-dead donors for liver transplantation. Many
of the patients included in this study were eventually used as
donors for liver transplantation. Therefore, although the
liver function tests were used to screen the potential donor
for evidence of liver disease, the low serum albumin levels
were ignored when making the decision whether to use the
donor as a liver donor or not. The impact of the hypoalbu-
minaemia on the outcome after liver transplantation remains
unresolved and did not form part of this study. 
In this study the serum albumin levels were not influenced
by the cause of brain death, the use of inotropic support, the
time since injury/CVA, and the time since the certification of
brain death. In contrast, serum albumin levels were influ-
TABLE I. SERUM ELECTROLYTE LEVELS AND
RENAL FUNCTION IN BRAIN-DEAD DONORS FOR
LIVER TRANSPLANTATION
Serum electrolytes (mmol/l)
Na+ 140.9 ± 8.8 
K+ 4.0 ± 0.9 
Urea 4.9 ± 2.1 
Creatinine 97.9 ± 37.0 
Ca2+ 1.5 ± 0.2 
Glucose 16.4 ± 9.3 
TABLE II. LIVER FUNCTION TEST RESULTS IN
BRAIN-DEAD DONORS FOR LIVER 
TRANSPLANTATION
Total protein 49.4 ± 21 g/l
Albumin 23.3 ± 7.4 g/l
Alk po4 60.4 ± 44.8 IU/l
GGT 27.7 ± 26.6 IU/l
ALT 36.8 ± 31.4 IU/l
AST 54.6 ± 31.6 IU/l
LDH 534.3 ± 328.9 IU/l
Conj. bilirubin 3.6 ± 2.6 µmol/l
Total bilirubin 14.1 ± 9.4 µmol/l
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Fig. 1. Causes of brain death in potential donors for liver
transplantation.
Fig. 2. Time between the injury/CVA and referral to the organ
transplant unit.
Fig. 3. Time between certification of brain death and referral
to the organ transplant unit.
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enced by the cause of the brain death; the trauma-related
brain-dead patients had significantly lower serum albumin
levels.
The precise cause of the low serum albumin levels follow-
ing brain death remains unresolved. Hypoalbuminaemia has
been documented previously in association with severe head
injury.1-4 The hypoalbuminaemia has been attributed to the
hypermetabolism/hypercatabolism seen in these patients.
Brain-injured patients are thought to have depressed serum
albumin levels due to the negative nitrogen balance as part of
the acute response to injury.3 However, this does not explain
why the patients who had sustained a CVA had low serum
albumin levels since the injury would have been relatively
minimal. 
Hypoalbuminaemia in association with clinical brain death
has not been documented previously. Furthermore the previ-
ous studies have all demonstrated the low serum albumin
levels in patients with severe head injury. The present finding
of hypoalbuminaemia following CVA has not been reported
previously.
It is also interesting to note how soon after the head
injury/CVA hypoalbuminaemia is detected. In 9 patients the
hypoalbuminaemia was noted within 10 hours of the
injury/CVA. The previous studies of head injury patients
were undertaken beyond 24 hours. The majority of the
patients in this study presented more than 10 hours after the
injury/CVA. Further studies are required of the period
immediately after the injury/CVA to determine how quickly
the hypoalbuminaemia occurs.
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Fig. 4. Distribution of total serum protein levels.
Fig. 6. Effect of inotropes on serum albumin levels.
Fig. 5. Distribution of serum albumin levels. 
Fig. 7. Effect of the cause of brain death on serum albumin
levels.
         
